Balyasny Asset Management LLC Legend Biotech Corp Transaction History
Balyasny Asset Management LLC
- $63.6 Billion
- Q4 2024
A detailed history of Balyasny Asset Management LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 119,400 shares of LEGN stock, worth $4.74 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
119,400
Previous 681,174
82.47%
Holding current value
$4.74 Million
Previous $33.2 Million
88.3%
% of portfolio
0.01%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
231Shares Held
86MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$298 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$270 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$238 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$227 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$227 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.65B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...